FindTrial
Sign In

Andrographis paniculata extract,Placebo

2 trials

Sponsors

Thai Traditional Medicine Knowlegde funding, Health System Research Institute

Conditions

COVID-19 patienrs, RT-PCR confirmed Covid-19 treatment Andrographidis paniculatae extract PneumoniaDecember 2019, an outbreak of pneumonia caused by a novel coronavirus occurred in China. As of 18-May-2021, a total of 162.7 million cases COVID-19 cases with 434,796 and 3.3 million deaths have been reported globally. This pandemic disease is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes diseases ranging from common cold to severe disease. The common signs and symptoms of infection include fever, URI symptom as cough, runny

Phase 1

Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial
Active, not recruitingTCTR20210708001
Thai Traditional Medicine Knowlegde fundingDecember 2019, an outbreak of pneumonia caused by a novel coronavirus occurred in China. As of 18-May-2021, a total of 162.7 million cases COVID-19 cases with 434,796 and 3.3 million deaths have been reported globally. This pandemic disease is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes diseases ranging from common cold to severe disease. The common signs and symptoms of infection include fever, URI symptom as cough, runny
Start: 2020-11-25Target: 60Updated: 2026-08-03

Phase 3

Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trial
RecruitingTCTR20211224002
Health System Research InstituteCOVID-19 patienrs, RT-PCR confirmed Covid-19 treatment Andrographidis paniculatae extract Pneumonia
Start: 2021-12-08Target: 736Updated: 2026-08-03